[Hemoglobin S haplotypes: their epidemiologic, anthropologic and clinical importance]

Area of Science:

• Genetics
• Hematology
• Anthropology

Background:

• Sickle cell disease (SCD) exhibits significant clinical variability.
• Understanding the genetic factors influencing SCD severity is crucial for patient management.
• Beta s-gene haplotypes are key determinants of SCD's biological manifestations.

Purpose of the Study:

• To explore the relationship between beta s-gene haplotypes and the clinical heterogeneity of sickle cell disease.
• To identify genetic markers that predict disease severity and prognosis.
• To understand the anthropological significance of beta s-gene haplotypes in population genetics.

Main Methods:

• Analysis of beta s-gene cluster polymorphisms and their association with clinical phenotypes.
• Assessment of fetal hemoglobin (HbF) levels, globin chain ratios (G gamma/A gamma), and other molecular factors.
• Utilizing advanced laboratory methods to differentiate SCD genotypes and rule out confounding hereditary factors.

Main Results:

• Specific beta s-gene haplotypes (Sen, Arab/Indian) are associated with milder SCD.
• Other haplotypes (Central African Republic/Bantu, Cameroon, Benin) are linked to severe SCD.
• The CAR haplotype indicates the poorest prognosis, characterized by low HbF levels and specific G gamma:A gamma ratios.

Conclusions:

• Beta s-gene haplotypes are significant predictors of sickle cell disease severity and clinical outcomes.
• These DNA polymorphisms serve as valuable anthropologic and genetic markers, aiding in understanding population origins.
• Variability in beta s-haplotypes contributes to the diverse genetic landscape within and between Black populations globally.